Tag Archives: Zogenix

Northland Securities Remains a Buy on Zogenix (ZGNX)

In a report released today, Carl Byrnes from Northland Securities maintained a Buy rating on Zogenix (ZGNX – Research Report), with a price target of $60. The company’s shares closed yesterday at $47.48. Byrnes observed: “We are reiterating our OP

Northland Securities Keeps a Buy Rating on Zogenix (ZGNX)

In a report released today, Carl Byrnes from Northland Securities maintained a Buy rating on Zogenix (ZGNX – Research Report), with a price target of $60. The company’s shares closed on Friday at $47.72. Byrnes wrote: “We note that 1504

Zogenix (ZGNX) Gets a Buy Rating from William Blair

In a report released today, Tim Lugo from William Blair maintained a Buy rating on Zogenix (ZGNX – Research Report). The company’s shares closed yesterday at $51.85. According to TipRanks.com, Lugo is a 4-star analyst with an average return of

Mizuho Securities Keeps Their Buy Rating on Zogenix (ZGNX)

Mizuho Securities analyst Difei Yang maintained a Buy rating on Zogenix (ZGNX – Research Report) today and set a price target of $69. The company’s shares closed yesterday at $52.67. Yang said: “We gave consideration to (70% PoS). DCF: We

Mizuho Securities Remains a Buy on Zogenix (ZGNX)

In a report released today, Difei Yang from Mizuho Securities maintained a Buy rating on Zogenix (ZGNX – Research Report), with a price target of $69. The company’s shares closed yesterday at $52.58. Yang commented: “We believe FINTEPLA’s unique mechanism

Mizuho Securities Assigns a Buy Rating on Zogenix (ZGNX)

Mizuho Securities analyst Difei Yang assigned a Buy rating to Zogenix (ZGNX – Research Report) today and set a price target of $69. The company’s shares closed yesterday at $45.66. Yang observed: “We note that the competitor product Epidiolex has